|
Volumn 9, Issue 6, 2000, Pages 1243-1256
|
Microbial pathogens and apoptotic anticancer therapy
|
Author keywords
Adenovirus; Apoptin; Apoptosis; Bordetella pertussis; Cancer; Caspases; Clostridium difficile; Escherichia coli; Helicobacter pylori; HIV 1 Vpr; Intracellular delivery technology; Mycobacteria; Resistance to apoptosis; Staphylococcus aureus; Viruses
|
Indexed keywords
ALPHA TOXIN;
AMPHOTERICIN;
ANTINEOPLASTIC AGENT;
APOPTIN;
ASPARAGINASE;
BACTERIAL ENZYME;
BACTERIAL TOXIN;
BORTEZOMIB;
BOTULINUM TOXIN;
CANCER VACCINE;
CASPASE 3;
CYTOKINE;
DAUNORUBICIN;
DOXORUBICIN;
GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;
HEMOLYSIN;
INTERFERON;
IXOSULIN;
LEUKOTOXIN;
LIVE VACCINE;
METHIONINE GAMMA LYASE;
N (4 AMINOBUTYL) 2 NAPSYLAMIDE;
PRODRUG;
RAPAMYCIN;
RECOMBINANT PROTEIN;
SHIGA TOXIN;
SULINDAC;
UNCLASSIFIED DRUG;
VIRUS PROTEIN;
ADENOVIRUS;
APOPTOSIS;
BORDETELLA PERTUSSIS;
CANCER;
CELL PROLIFERATION;
CIRCOVIRIDAE;
CLINICAL TRIAL;
CLOSTRIDIUM DIFFICILE;
CYTOKINE PRODUCTION;
DRUG DELIVERY SYSTEM;
DRUG DESIGN;
DRUG TARGETING;
ESCHERICHIA COLI;
HELICOBACTER PYLORI;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1;
MULTIDRUG RESISTANCE;
MYCOBACTERIUM;
PATHOGENICITY;
REVIEW;
STAPHYLOCOCCUS AUREUS;
TUMOR CELL DESTRUCTION;
VIRUS ATTENUATION;
|
EID: 0034128234
PISSN: 13543784
EISSN: None
Source Type: Journal
DOI: 10.1517/13543784.9.6.1243 Document Type: Review |
Times cited : (2)
|
References (126)
|